International
EpiVacCorona: Russia’s second COVID-19 vaccine
Kathmandu. Russia has completed the second phase of vaccination against coronavirus. The vaccine named EpiVacCorona is being prepared at the Vektor State Research Center of Virology and Biotechnology in Siberia. The Center expressed on Thursday that the first two-phase trial of the vaccine had received good results. Russia had previously announced its first vaccine against
No ads found for this position
Trending News
- This Week
- This Month
